COM:ORCHARD-TX
Orchard Therapeutics
- Stock
Last Close
16.65
23/01 21:00
Market Cap
380.11M
Beta: -
Volume Today
372.35K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
net income | -19.09M - | -39.74M 108.25% | -230.50M 479.95% | -163.42M 29.10% | -151.98M 7.00% | -144.58M 4.87% | -150.66M 4.20% | |
depreciation and amortization | 6K - | 302K 4,933.33% | 1.20M 297.02% | 1.68M 39.70% | 2.00M 19.64% | 2.33M 16.12% | 2.74M 17.79% | |
deferred income tax | -6.30M - | -6.39M 1.43% | -2.26M 64.68% | 1.13M 150.11% | -3.28M 390.27% | |||
stock based compensation | 204K - | 1.02M 399.51% | 6.77M 563.98% | 19.42M 187.08% | 27.96M 43.96% | 22.54M 19.40% | 16.01M 28.96% | |
change in working capital | 1.51M - | 2.81M 86.22% | 36.52M 1,199.57% | -17.73M 148.55% | -3.63M 79.54% | -17.06M 370.31% | 36.20M 312.18% | |
accounts receivables | -927K - | 715K 177.13% | 582K 18.60% | -624K 207.22% | -7.42M 1,089.10% | |||
inventory | 15.72M - | -10.61M 167.49% | -5.23M 50.72% | -20.11M 284.71% | ||||
accounts payables | 666K - | 1.93M 189.79% | 14.85M 669.33% | -6.41M 143.19% | -1.55M 75.78% | -9.45M 508.63% | 13.64M 244.33% | |
other working capital | 843K - | 880K 4.39% | 6.88M 681.82% | -1.42M 120.70% | 2.57M 280.48% | 13.12M 410.58% | 29.98M 128.49% | |
other non cash items | 2.80M - | 3.13M 11.64% | 94.78M 2,931.86% | 311K 99.67% | 1.62M 422.19% | 10.56M 550% | 23.00M 117.90% | |
net cash provided by operating activities | -14.57M - | -32.49M 123.03% | -97.54M 200.23% | -166.13M 70.33% | -126.27M 23.99% | -125.10M 0.93% | -75.99M 39.26% | |
investments in property plant and equipment | -190K - | -1.56M 720.53% | -4.03M 158.63% | -4.37M 8.31% | -12.67M 190.08% | -3.23M 74.46% | -6.51M 101.36% | |
acquisitions net | 304.99M - | 887K - | ||||||
purchases of investments | -414.01M - | -113.26M 72.64% | -263.88M 132.98% | -112.28M 57.45% | ||||
sales maturities of investments | 109.02M - | 281.43M 158.15% | 234.73M 16.59% | 201.39M 14.20% | ||||
other investing activites | -304.99M - | 1.88M 100.62% | -671K 135.77% | 7.97M 1,287.18% | ||||
net cash used for investing activites | -190K - | -1.56M 720.53% | -4.03M 158.63% | -309.36M 7,572.57% | 157.38M 150.87% | -32.16M 120.44% | 90.56M 381.55% | |
debt repayment | -786K - | |||||||
common stock issued | 205.47M - | 130.27M 36.60% | 154.13M - | |||||
common stock repurchased | -392K - | -19K 95.15% | ||||||
dividends paid | ||||||||
other financing activites | 18.03M - | 115.70M 541.54% | 149.40M 29.13% | 27.18M 81.80% | 3.94M 85.52% | 4.32M 9.83% | 112K 97.41% | |
net cash used provided by financing activities | 18.03M - | 115.70M 541.54% | 354.86M 206.72% | 157.45M 55.63% | 3.94M 97.50% | 158.07M 3,915.90% | -693K 100.44% | |
effect of forex changes on cash | -751K - | 4.71M 727.03% | -3.47M 173.71% | 1.67M 148.17% | 1.04M 37.62% | -27K 102.59% | -1.42M 5,155.56% | |
net change in cash | 2.53M - | 86.36M 3,317.45% | 249.82M 189.29% | -316.36M 226.63% | 36.08M 111.41% | 777K 97.85% | 12.46M 1,503.73% | |
cash at beginning of period | 970K - | 3.50M 260.52% | 89.86M 2,469.52% | 339.68M 278.03% | 23.32M 93.14% | 59.40M 154.75% | 60.18M 1.31% | |
cash at end of period | 3.50M - | 89.86M 2,469.52% | 339.68M 278.03% | 23.32M 93.14% | 59.40M 154.75% | 60.18M 1.31% | 72.64M 20.71% | |
operating cash flow | -14.57M - | -32.49M 123.03% | -97.54M 200.23% | -166.13M 70.33% | -126.27M 23.99% | -125.10M 0.93% | -75.99M 39.26% | |
capital expenditure | -190K - | -1.56M 720.53% | -4.03M 158.63% | -4.37M 8.31% | -12.67M 190.08% | -3.23M 74.46% | -6.51M 101.36% | |
free cash flow | -14.76M - | -34.05M 130.73% | -101.57M 198.33% | -170.50M 67.87% | -138.94M 18.51% | -128.33M 7.64% | -82.50M 35.71% |
All numbers in (except ratios and percentages)